Stalfort John A III has filed 12 insider transactions across 3 companies since June 2023.
Most recent transaction: a grant/award of 12800 shares of Acumen Pharmaceuticals, Inc. ($ABOS) on June 04, 2025.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 4, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Stalfort John A III | Director | A | Common Stock | 12800 | $0.00 | 185,124.0000 | 60,573,425 | 7.43% | 0.02% |
| June 4, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Stalfort John A III | Director | A | Stock Option (right to buy) | 19500 | $0.00 | 19,500.0000 | 60,573,425 | 9999.99% | 0.03% |
| June 2, 2025 | Taysha Gene Therapies, Inc. | $TSHA | Stalfort John A III | Not found | A | Common Stock | 56623 | $0.00 | 2,039,514.0000 | 250,134,421 | 2.86% | 0.02% |
| June 2, 2025 | Taysha Gene Therapies, Inc. | $TSHA | Stalfort John A III | Not found | A | Stock Option (right to buy) | 113246 | $0.00 | 113,246.0000 | 250,134,421 | 9999.99% | 0.05% |
| Nov. 22, 2024 | Verrica Pharmaceuticals Inc. | $VRCA | Stalfort John A III | Not found | P | Series A Warrants (right to buy) | 561797 | $0.00 | 561,797.0000 | 0 | 9999.99% | 0.00% |
| Nov. 26, 2024 | Verrica Pharmaceuticals Inc. | $VRCA | Stalfort John A III | Not found | G | Common Stock | 50000 | $0.00 | 1,873,800.0000 | 0 | 2.74% | 0.00% |
| Nov. 22, 2024 | Verrica Pharmaceuticals Inc. | $VRCA | Stalfort John A III | Not found | P | Common Stock | 1123595 | $0.00 | 1,823,800.0000 | 0 | 160.47% | 0.00% |
| Nov. 22, 2024 | Verrica Pharmaceuticals Inc. | $VRCA | Stalfort John A III | Not found | P | Series B Warrants (right to buy) | 561797 | $0.00 | 561,797.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2024 | Acumen Pharmaceuticals, Inc. | $ABOS | Stalfort John A III | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 29, 2024 | Taysha Gene Therapies, Inc. | $TSHA | Stalfort John A III | Not found | A | Common Stock | 49220 | $0.00 | 1,982,891.0000 | 116,121,482 | 2.55% | 0.04% |
| May 29, 2024 | Taysha Gene Therapies, Inc. | $TSHA | Stalfort John A III | Not found | A | Stock Option (right to buy) | 98440 | $0.00 | 98,440.0000 | 116,121,482 | 9999.99% | 0.08% |
| June 6, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | Stalfort John A III | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |